Search Results

While the full impact of the Supreme Court decision remains unknown, the new regulatory landscape could be a net positive for drug developers.

The U.S. Supreme Court on Friday overturned the long-standing Chevron doctrine, which required courts to defer to federal agencies and their interpretation of statutes, putting potential limits on the FDA’s regulatory decisions.

The U.S. Supreme Court on Friday overturned the long-standing Chevron doctrine, which required courts to defer to federal agencies and their interpretation of statutes, putting potential limits on the FDA’s regulatory decisions.

Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”) today announced it is expanding its collaboration with Chevron Phillips Chemical (“CPChem”) to explore development and commercialization of cast extrusion films, blown extrusion films, injection molded parts and rotational molded parts using Rinnovo™ polymers produced in a loop slurry reactor process.

Epicore Biosystems has announced an agreement with Chevron U.S.A. Inc. to evaluate wearable sensors to track dehydration biomarkers of ‘industrial athletes’ in field settings.

Harpak-ULMA announced availability of a flow-pack solution capable of applying a chevron seal for medical packaging.

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.